Influence of the 'Directions for use' on positivity rates of the Hemoccult II® test

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 12, 1998, Pages 1021-1024

  Faure, Henri ^a   Exbrayat, Catherine ^b   Garnier, Anne ^b   Dumas, Pierre ^a   Winckel, Philippe ^b   Bolla, Michel ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b Off Departemental Lutte Contre L   (France)

Author keywords

Colorectal neoplasm diagnosis; Occult blood; Stool sample

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OCCULT BLOOD; PRIORITY JOURNAL;

EID: 0032436177     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199812000-00007     Document Type: Article

References (18)

1. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of fecal-occult-blood screening for colorectal cancer. Lancet 1996; 348:1472-1477.
2. Kronborg O, Fengen C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with fecal-occult-blood test. Lancet 1996; 348:1467-1471.
3. Mandel JS, Bond JH, Church TR, Snover DC, Bradley M, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328:1365-1371.
4. Faivre J, Tazi M-A. La recherche d'un saignement occulte dans les selles: un moyen pour diminuer la mortalité par cancer colo-rectal? Gastroentérol Clin Biol 1996; 20:225-227.
5. Faivre J, Bader JP, Bertario L, Besbeas S, Castiglione G, Chamberlain J, et al. Mass screening for colorectal cancer: statement of the European group for colorectal cancer screening. Eur J Cancer Prev 1995; 4:437-439.
6. ANAES Conférence de consensus. Prévention, dépistage et prise en charge des cancers du côlon. Gastroentérol Clin Biol 1998; 22:205-218.
7. Bolla M, Winckel P, Garnier A, Exbrayat C, Billette de Villeumeur A. L'office départemental de lutte contre le cancer, une structure de dépistage en lsère. Bull Cancer 1996; 83:750-754.
8. Exbrayat C, Garnier A, Bolla M, Winckel P, Salicru B, Marron J, et al. Dépistage simultané des cancers du sein, du col utérin, du colon et du rectum. Expérience de l'lsère. Bull Cancer 1996; 83:641-648.
9. SKD France. Prévention et Biologie. Hemoccult II 'Instructions for use'.
10. 59Fe elimination rates. Klin Wochenchr 1980; 58:1283-1297.
11. Saito H, Tsuchida S, Nakaji S, Kakizaki R, Aisawa T, Munakada A, et al. An immunologic test for fecal occult blood by counter immunoelectrophoresis. Higher sensitivity and higher positive reactions in colorectal cancer than single radial immunodiffusion and hemoccult test. Cancer 1985; 56:1549-1552.
12. Sokal RR, Rohlf FJ. Biometry: the Principles and Practice of Statistics in Biological Research. New York: W.H. Freeman & Co.; 1995. pp. 741-743.
13. Duchastaing D. Quality insurance of the pre-analytic step: sampling. Ann Biol Clin 1997; 55:497-508.
14. Macrae FA, St John JB, Caligiore P, Taylor LS, Legge JW. Optimal dietary conditions for Hemoccult testing. Gastroenterology 1982; 82:899-903.
15. Caligiore P, Macrae FA, St John DJB, Rayner LJ, Legge JW. Peroxidase levels in food: relevance to colorectal cancer screening. Am J Clin Nutr 1982; 35:1487-1489.
16. Simon JB. Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology 1985; 88:820-837.
17. Allison JE, Tekawa IS, Ransom LJ, Adrain L. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334:155-159.
18. Ahlquist DA, Schwartz S, Isaacson J, Ellefson M. A stool collection device: the first step in occult blood testing. Ann Intern Med 1988; 108:609-612.